Pfizer’s Stock Is Down 44% YTD As Woes Continue By: TalkMarkets December 01, 2023 at 10:33 AM EST Pfizer's shares plunged on Friday after the drugmaker halted the trial of its twice-daily obesity drug. Read More >> Related Stocks: Eli Lilly Novo Nordisk A/S ADR Pfizer
